Deval, Jerome
Janssen Research & Development,
United States
2024 Rank: 226814
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1166 out of 71672 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 226814 | 249357 |
| Total Cites | 243 | 259 |
| H-index | 8 | 9 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 34 | 38 |
| Number of Single+First+Last Authored Papers | 34 | 34 |
| Total Cites to Single+First+Last Authored Papers | 140 | 147 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 218 | 226 |
| Ratio of Total Citations to Distinct Citing Papers | 1.11 | 1.15 |
| Self-Citation Percentage |
6.18%
|
|
Deval, Jerome
Aligos Therapeutics, Inc.,
United States
2023 Rank: 165762
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 975 out of 68279 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 165762 | 180668 |
| Total Cites | 298 | 311 |
| H-index | 10 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 35 | 35 |
| Number of Single+First+Last Authored Papers | 34 | 34 |
| Total Cites to Single+First+Last Authored Papers | 224 | 228 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 255 | 264 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.18 |
| Self-Citation Percentage |
4.18%
|
|
Deval, Jerome
Aligos Therapeutics, Inc.,
United States
2022 Rank: 117069
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 788 out of 65731 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 117069 | 127768 |
| Total Cites | 336 | 356 |
| H-index | 10 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 54 | 55 |
| Number of Single+First+Last Authored Papers | 33 | 33 |
| Total Cites to Single+First+Last Authored Papers | 265 | 278 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 274 | 288 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.24 |
| Self-Citation Percentage |
5.62%
|
|
Deval, Jerome
Aligos Therapeutics, Inc.,
United States
2021 Rank: 165925
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Virology
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 1076 out of 64670 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 165925 | 183206 |
| Total Cites | 382 | 411 |
| H-index | 12 | 12 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 54 | 59 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 309 | 325 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 316 | 333 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.23 |
| Self-Citation Percentage |
7.06%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.